Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -16.17%. However, over the last six months, the performance has been stronger by -4.84%. The price of PFE decreased -4.65% over the last 30 days. And in the last five days, it has surged by 4.64%.
Pfizer Inc (PFE) current stock price is $24.58. During the last trading session, the stock soared, reaching $38.0 after opening at $24.58. The stock’s lowest point was $24.0 before it closed at $24.23.
The market performance of Pfizer Inc has been somewhat unstable.
52-week price history of PFE Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Pfizer Inc’s current trading price is -19.22% away from its 52-week high, while its distance from the 52-week low is 17.52%. The stock’s price range over this timeframe has been between $20.92 and $30.43. The shares of the Healthcare sector company recorded a trading volume of approximately 36.34 million for the day, which was comparatively lower than the average daily volume of 42.72 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Pfizer Inc (PFE) has experienced a quarterly rise of 7.01% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 139.75B and boasts a workforce of 81000 employees.
Expert Opinions: Analysts’ Ratings for Pfizer Inc
As of right now, 7 analysts are rating Pfizer Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 23.96, with a change in price of -1.47. Similarly, Pfizer Inc recorded 49,152,949 in trading volume during the last 100 days, posting a change of -5.64%.
PFE’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PFE stands at 0.70. Similarly, the long-term debt-to-equity ratio is also 0.65.
PFE Stock Stochastic Average
Pfizer Inc’s raw stochastic average for the past 50 days is currently at 50.84%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 58.33%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 43.07% and 39.32%, respectively.
